These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 33254494)

  • 1. Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5/14.
    Murch SH
    Med Hypotheses; 2020 Nov; 144():110168. PubMed ID: 33254494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways.
    Angata T; Varki A
    J Biol Chem; 2000 Jul; 275(29):22127-35. PubMed ID: 10801860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD33-related siglecs on human mononuclear phagocytes, monocyte-derived dendritic cells and plasmacytoid dendritic cells.
    Lock K; Zhang J; Lu J; Lee SH; Crocker PR
    Immunobiology; 2004; 209(1-2):199-207. PubMed ID: 15481154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9.
    Ikehara Y; Ikehara SK; Paulson JC
    J Biol Chem; 2004 Oct; 279(41):43117-25. PubMed ID: 15292262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?
    Cao H; Crocker PR
    Immunology; 2011 Jan; 132(1):18-26. PubMed ID: 21070233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
    Avril T; Floyd H; Lopez F; Vivier E; Crocker PR
    J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ganglioside binding pattern of CD33-related siglecs.
    Rapoport E; Mikhalyov I; Zhang J; Crocker P; Bovin N
    Bioorg Med Chem Lett; 2003 Feb; 13(4):675-8. PubMed ID: 12639556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OB-BP1/Siglec-6. a leptin- and sialic acid-binding protein of the immunoglobulin superfamily.
    Patel N; Brinkman-Van der Linden EC; Altmann SW; Gish K; Balasubramanian S; Timans JC; Peterson D; Bell MP; Bazan JF; Varki A; Kastelein RA
    J Biol Chem; 1999 Aug; 274(32):22729-38. PubMed ID: 10428856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning and characterization of human Siglec-11. A recently evolved signaling molecule that can interact with SHP-1 and SHP-2 and is expressed by tissue macrophages, including brain microglia.
    Angata T; Kerr SC; Greaves DR; Varki NM; Crocker PR; Varki A
    J Biol Chem; 2002 Jul; 277(27):24466-74. PubMed ID: 11986327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy approaches on innate immunity for SARS-Cov-2.
    Arslan BA; Timucin AC
    Acta Virol; 2020; 64(4):389-395. PubMed ID: 32985199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profiling of immune inhibitory Siglecs and their ligands in patients with glioma.
    Santegoets KCM; Gielen PR; Büll C; Schulte BM; Kers-Rebel ED; Küsters B; Bossman SAJFH; Ter Laan M; Wesseling P; Adema GJ
    Cancer Immunol Immunother; 2019 Jun; 68(6):937-949. PubMed ID: 30953118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural ligands for CD33-related Siglecs?
    Varki A
    Glycobiology; 2009 Aug; 19(8):810-2. PubMed ID: 19429924
    [No Abstract]   [Full Text] [Related]  

  • 13. A new siglec family member, siglec-10, is expressed in cells of the immune system and has signaling properties similar to CD33.
    Whitney G; Wang S; Chang H; Cheng KY; Lu P; Zhou XD; Yang WP; McKinnon M; Longphre M
    Eur J Biochem; 2001 Dec; 268(23):6083-96. PubMed ID: 11733002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-affinity ligands of Siglec receptors and their therapeutic potentials.
    Magesh S; Ando H; Tsubata T; Ishida H; Kiso M
    Curr Med Chem; 2011; 18(23):3537-50. PubMed ID: 21756229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the asparagine-linked oligosaccharides on siglec-5, siglec-7 and siglec-8, expressed in a CHO cell line, and their contribution to ligand recognition.
    Freeman S; Birrell HC; D'Alessio K; Erickson-Miller C; Kikly K; Camilleri P
    Eur J Biochem; 2001 Mar; 268(5):1228-37. PubMed ID: 11231274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lectin galactoside-binding soluble 3 binding protein (LGALS3BP) is a tumor-associated immunomodulatory ligand for CD33-related Siglecs.
    Läubli H; Alisson-Silva F; Stanczak MA; Siddiqui SS; Deng L; Verhagen A; Varki N; Varki A
    J Biol Chem; 2014 Nov; 289(48):33481-91. PubMed ID: 25320078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD33/Siglec-3 binding specificity, expression pattern, and consequences of gene deletion in mice.
    Brinkman-Van der Linden EC; Angata T; Reynolds SA; Powell LD; Hedrick SM; Varki A
    Mol Cell Biol; 2003 Jun; 23(12):4199-206. PubMed ID: 12773563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic and clinical immunology of Siglecs.
    von Gunten S; Bochner BS
    Ann N Y Acad Sci; 2008 Nov; 1143():61-82. PubMed ID: 19076345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human brain sialoglycan ligand for CD33, a microglial inhibitory Siglec implicated in Alzheimer's disease.
    Gonzalez-Gil A; Porell RN; Fernandes SM; Maenpaa E; Li TA; Li T; Wong PC; Aoki K; Tiemeyer M; Yu ZJ; Orsburn BC; Bumpus NN; Matthews RT; Schnaar RL
    J Biol Chem; 2022 Jun; 298(6):101960. PubMed ID: 35452678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer.
    Läubli H; Pearce OM; Schwarz F; Siddiqui SS; Deng L; Stanczak MA; Deng L; Verhagen A; Secrest P; Lusk C; Schwartz AG; Varki NM; Bui JD; Varki A
    Proc Natl Acad Sci U S A; 2014 Sep; 111(39):14211-6. PubMed ID: 25225409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.